Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Cigna    CI

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsSector newsTweets

CIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With Anthem

share with twitter share with LinkedIn share with facebook
share via e-mail
02/16/2017 | 03:32pm CET
By Brent Kendall 

A Delaware judge on Wednesday issued a temporary restraining order that blocks Cigna Corp. from immediately terminating its troubled $48 billion merger with rival health insurer Anthem Inc.

The development is the latest in what could be a long and bitter legal battle between the two companies in the wake of a federal judge's ruling earlier this month that the proposed merger violates U.S. antitrust law.

Cigna on Tuesday declared it was done with the merger and sued Anthem, seeking a $1.85 billion breakup fee plus more than $13 billion in damages from its deal partner. Anthem then responded with its own lawsuit and sought an immediate order stopping Cigna from ending their pact.

Anthem obtained such an order Wednesday from Vice Chancellor J. Travis Laster, a judge on the Delaware Chancery Court, according to a Thursday filing by Cigna with the Securities and Exchange Commission.

Under the terms of the merger agreement, Anthem could extend the deal until the end of April. The firm is making a long-shot bid to win a quick appeal of U.S. District Judge Amy Berman Jackson's ruling that the merger would unlawfully harm consumers and competition.

Both Anthem and Cigna have accused one another of violating their 2015 merger deal. Cigna said Anthem's alleged violations meant it couldn't extend the merger agreement until April. Anthem said Cigna has been engaged in a campaign to sink the deal.

Cigna in a statement said, "This is not a decision on the merits of the case, but rather a procedural order to ensure irrevocable actions do not take place before the court's substantive review of the issues. Cigna respects the court's decision and will continue to abide by terms of the merger agreement until the court further reviews the case."

The insurer said another hearing will be scheduled the week of April 10.

Anthem didn't respond to a request for comment on the restraining order.

Write to Brent Kendall at [email protected]

Valeurs citées dans l'article
ChangeLast1st jan.
ANTHEM INC 0.46% 232.97 Delayed Quote.4.45%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on CIGNA
03:01pCIGNA CORPORATION : Announces Appearance at the Barclays Global Healthcare Confe..
01:12pCIGNA : Free Post Earnings Research Report: Cigna's Q4 Results Rose to Outshine ..
02/20CIGNA : Wendy Sherry Named Market President for Cigna's Commercial Business in C..
02/03CIGNA : Increases Minimum Wage To $16 An Hour
02/01CIGNA : Earns Military Friendly® Designation for Strong Veterans Hiring Programs
02/01CIGNA : Named a "Best Place to Work for LGBTQ Equality" for Sixth Year in a Row
02/01CIGNA (NYSE : CI) reported earnings of $1.94 per share beating Walls Streets exp..
02/01CIGNA : Corporation to Host Earnings Call
02/01CIGNA CORP : Results of Operations and Financial Condition, Financial Statements..
02/01CIGNA : Delivers Strong 2017 Results, Expects Continued Revenue and Earnings Gro..
More news
News from SeekingAlpha
02/20HHS debuts new rule allowing increased access to short-term insurance plans 
02/18Tracking George Soros's Portfolio - Q4 2017 Update 
02/01Cigna's (CI) CEO David Cordani on Q4 2017 Results - Earnings Call Transcript 
02/01Cigna Corp. 2017 Q4 - Results - Earnings Call Slides 
02/01Cigna Q4 revenues up 6%; non-GAAP EPS up 4%; updates guidance 
Financials ($)
Sales 2018 44 240 M
EBIT 2018 3 938 M
Net income 2018 2 943 M
Debt 2018 3 400 M
Yield 2018 0,01%
P/E ratio 2018 16,01
P/E ratio 2019 14,00
EV / Sales 2018 1,16x
EV / Sales 2019 0,94x
Capitalization 47 784 M
Duration : Period :
Cigna Technical Analysis Chart | CI | US1255091092 | 4-Traders
Technical analysis trends CIGNA
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 237 $
Spread / Average Target 22%
EPS Revisions
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Eric Palmer Chief Financial Officer
Alan M. Muney Chief Medical Officer
Mark L. Boxer Global Chief Information Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA-3.71%47 784
ANTHEM INC4.45%60 344
AETNA-2.01%58 363
HUMANA7.82%38 429